Impact of Managed Care on Clinical Outcome of Systemic Lupus Erythematosus in Puerto Rico

2003 ◽  
Vol 9 (1) ◽  
pp. 25-32 ◽  
Author(s):  
Angel M. Mayor ◽  
Luis M. Vil?? ◽  
Miguel De La Cruz ◽  
Ricardo G??mez
Lupus ◽  
2012 ◽  
Vol 22 (1) ◽  
pp. 99-105 ◽  
Author(s):  
DE Furst ◽  
AE Clarke ◽  
AW Fernandes ◽  
T Bancroft ◽  
W Greth ◽  
...  

Lupus ◽  
2013 ◽  
Vol 23 (1) ◽  
pp. 39-45 ◽  
Author(s):  
J Lee ◽  
S-K Kwok ◽  
S-M Jung ◽  
H-K Min ◽  
H-C Nam ◽  
...  

2007 ◽  
Vol 13 (4) ◽  
pp. 202-204 ◽  
Author(s):  
Mar??a J. Molina ◽  
Angel M. Mayor ◽  
Alejandro E. Franco ◽  
Carlos A. Morell ◽  
Miguel A. L??pez ◽  
...  

2013 ◽  
Vol 16 (5) ◽  
pp. 667-677 ◽  
Author(s):  
Cindy Garris ◽  
Priti Jhingran ◽  
Damon Bass ◽  
Nicole M. Engel-Nitz ◽  
Aylin Riedel ◽  
...  

Lupus ◽  
2017 ◽  
Vol 26 (5) ◽  
pp. 497-503 ◽  
Author(s):  
J G Hanly

Neuropsychiatric events in systemic lupus erythematosus patients may present a diagnostic and therapeutic challenge. Common and heterogeneous, their characterization and attribution to systemic lupus erythematosus and non-systemic lupus erythematosus is important and derived from clinical assessment, selection and interpretation of investigations. A standardized approach to assigning attribution has been used in recent studies. The current therapies are largely empiric, based upon known disease mechanisms and treatment of other serious organ disease in systemic lupus erythematosus. Further insight on the immunopathogenetic mechanisms and clinical outcome of neuropsychiatric systemic lupus erythematosus is required to inform the design and execution of therapeutic clinical trials.


2018 ◽  
Vol 6 ◽  
pp. 205031211877838 ◽  
Author(s):  
Patricia Jordán-González ◽  
Lee Ming Shum ◽  
Lorena González-Sepúlveda ◽  
Luis M Vilá

Objective: Infections are a major cause of morbidity and mortality in systemic lupus erythematosus. Clinical outcomes of systemic lupus erythematosus patients hospitalized due to infections vary among different ethnic populations. Thus, we determined the outcomes and associated factors in a group of Hispanics from Puerto Rico with systemic lupus erythematosus admitted due to severe infections. Methods: Records of systemic lupus erythematosus patients admitted to the Adult University Hospital, San Juan, Puerto Rico, from January 2006 to December 2014 were examined. Demographic parameters, lupus manifestations, comorbidities, pharmacologic treatments, inpatient complications, length of stay, readmissions, and mortality were determined. Patients with and without infections were compared using bivariate and multivariate analyses. Results: A total of 204 admissions corresponding to 129 systemic lupus erythematosus patients were studied. The mean (standard deviation) age was 34.7 (11.6) years; 90% were women. The main causes for admission were lupus flare (45.1%), infection (44.0%), and initial presentation of systemic lupus erythematosus (6.4%). The most common infections were complicated urinary tract infections (47.0%) and soft tissue infections (42.0%). In the multivariate analysis, patients admitted with infections were more likely to have diabetes mellitus (odds ratio: 4.20, 95% confidence interval: 1.23–14.41), exposure to aspirin prior to hospitalization (odds ratio: 4.04, 95% confidence interval: 1.03–15.80), and higher mortality (odds ratio: 6.00, 95% confidence interval: 1.01–35.68) than those without infection. Conclusion: In this population of systemic lupus erythematosus patients, 44% of hospitalizations were due to severe infections. Patients with infections were more likely to have diabetes mellitus and higher mortality. Preventive and control measures of infection could be crucial to improve survival in these patients.


Sign in / Sign up

Export Citation Format

Share Document